See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$10.8B | 26.4x | 80.7x | |
$8.2B | 6.8x | 19.5x | |
$1.3B | 6.5x | -19.1x | |
$1.3B | 4.8x | -8.6x | |
$896M | 19.4x | n/a | |
$191M | 10.6x | 13.9x | |
$181M | n/a | n/a | |
$155M | 6.8x | -5.0x | |
$38.4M | 2.2x | 11.8x | |
$29.9M | 12.4x | -7.5x | |
$19.0M | n/a | -7.9x | |
$10.6M | n/a | n/a | |
-$17.1M | -0.6x | n/a | |
-$21.2M | n/a | 0.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics